Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety

Clinical trial NCT07216014 · RECRUITING

Trial details

NCT number: NCT07216014
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn's Disease and Ulcerative Colitis

Start date: 2025-12-01
Primary completion: 2026-09-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.